Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr;38(2):261-274.
doi: 10.1007/s00540-023-03291-4. Epub 2024 Jan 22.

Neurosteroids and their potential as a safer class of general anesthetics

Affiliations
Review

Neurosteroids and their potential as a safer class of general anesthetics

Hiroki Tateiwa et al. J Anesth. 2024 Apr.

Abstract

Neurosteroids (NS) are a class of steroids that are synthesized within the central nervous system (CNS). Various NS can either enhance or inhibit CNS excitability and they play important biological roles in brain development, brain function and as mediators of mood. One class of NS, 3α-hydroxy-pregnane steroids such as allopregnanolone (AlloP) or pregnanolone (Preg), inhibits neuronal excitability; these endogenous NS and their analogues have been therapeutically applied as anti-depressants, anti-epileptics and general anesthetics. While NS have many favorable properties as anesthetics (e.g. rapid onset, rapid recovery, minimal cardiorespiratory depression, neuroprotection), they are not currently in clinical use, largely due to problems with formulation. Recent advances in understanding NS mechanisms of action and improved formulations have rekindled interest in development of NS as sedatives and anesthetics. In this review, the synthesis of NS, and their mechanism of action will be reviewed with specific emphasis on their binding sites and actions on γ-aminobutyric acid type A (GABAA) receptors. The potential advantages of NS analogues as sedative and anesthetic agents will be discussed.

Keywords: Allopregnanolone; Alphaxalone; GABAA receptor; Neurosteroids.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflict of interest.

Figures

Fig. 1
Fig. 1
Chemical structure of cholesterol, allopregnanolone, progesterone and the synthetic anesthetic neurosteroids (alphaxalone and hydroxydione). Cholesterol has 27 carbons with a hydrocarbon (isooctyl) tail, a central steroid nucleus composed of four hydrocarbon rings (A, B, C, and D), and a hydroxyl group. The numbering of the carbon atoms indicates their position on the steroid ring or hydrocarbon tail. C3 is a carbon located on the A ring (circled), and 3-OH indicates that the hydroxyl group is connected to C3. The stereochemical configuration of the groups at the 3, 17, 18, 19, and 21 positions are shown by a dashed wedge (α-configuration) or a solid wedge (β-configuration). Note that cholesterol has a 3β-OH, whereas allopregnanolone and alphaxalone have 3α-OH groups. Progesterone and hydroxydione have ketone groups at C3
Fig. 2
Fig. 2
Biosynthetic pathways of neurosteroids. Abbreviations: 3α-HSD: 3α hydroxysteroid dehydrogenase, 3β-HSD: 3β hydroxysteroid dehydrogenase, AlloP: allopregnanolone, DHEA: dehydroepiandrosterone, DHEAS: dehydroepiandrosterone sulfate, DOC: deoxycorticosterone, Epi-AlloP: epi-allopregnanolone, P450scc: P450 side-chain cleavage, Preg: pregnanolone, PS: pregnenolone sulfate, StAR: steroidogenic acute regulatory protein, SULT: sulfotransferase, THDOC: tetrahydrodeoxycorticosterone
Fig. 3
Fig. 3
Model structures of GABAA receptor and neurosteroid binding sites. (a) Cryogenic-EM structure showing the side view and top view of GABAA receptor α1β3γ2 (PDB: 6I53). (b) α-subunits of GABAA receptor α1β3γ2 (PDB: 6I53) and pore. (ce) X-ray crystallographic structures of GABAA receptor TMD intersubunit site with ligand. (c) GLIC-GABAA receptor—THDOC (PDB: 5OSB). (d) β3 ECD-α5 TMD GABAA receptor—Preg (PDB: 5O8F). (e) ELIC-GABAA receptor—alphaxalone (PDB: 6CDU). (f) GABAA receptor α1β2γ2—AlloP (PDB: 8SI9)

References

    1. Selye H. Anesthetic Effect of Steroid Hormones. Proc Soc Exp Biol Med. 1941;46:116–121. doi: 10.3181/00379727-46-11907. - DOI
    1. Baulieu EE, Robel P. Neurosteroids: a new brain function? J Steroid Biochem Mol Biol. 1990;37(3):395–403. doi: 10.1016/0960-0760(90)90490-C. - DOI - PubMed
    1. Baulieu EE. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology. 1998;23(8):963–987. doi: 10.1016/S0306-4530(98)00071-7. - DOI - PubMed
    1. Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer-Brody S. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet. 2017;390(10093):480–489. doi: 10.1016/S0140-6736(17)31264-3. - DOI - PubMed
    1. Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A, Jonas J, Kanes S. Brexanolone injection in post-partum depression: two multicentre, doubleblind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392(10152):1058–1070. doi: 10.1016/S0140-6736(18)31551-4. - DOI - PubMed

MeSH terms

LinkOut - more resources